The Aerobika(R) Device, Marketed by Monaghan Medical in the United States, Benefits COPD Patients and Wins Gold at MDEA Awards
July 16, 2014 14:38 ET | Monaghan Medical Corporation
PLATTSBURGH, NY--(Marketwired - Jul 16, 2014) - The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the...
Aquinox Pharmaceuticals Announces Closing of Initial Public Offering
March 12, 2014 12:58 ET | Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 12, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Nasdaq:AQXP) announced today the closing of its initial public offering of 4,830,000 shares of its...
Aquinox Pharmaceuticals Prices Initial Public Offering
March 07, 2014 09:00 ET | Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 7, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 4,200,000 shares of its common stock at a...
Do More With Oxygen Helps Those With COPD and Their Caregivers Better Understand the Disease With Free Guide
January 16, 2013 09:25 ET | Do More With Oxygen
CLEVELAND, OH--(Marketwire - Jan 16, 2013) -  Understanding Chronic Obstructive Pulmonary Disease (COPD) and its symptoms can be confusing for those recently diagnosed with the disease and...
Pearl Therapeutics Logo
Pearl Therapeutics Issued U.S. Patent on Co-Suspension Formulation Technology
December 05, 2012 08:00 ET | Pearl Therapeutics
REDWOOD CITY, CALIF., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the U.S. Patent and Trademark Office has issued a patent on its novel co-suspension formulation...